Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Active

RFA-CA-28-013Grant

Response Deadline02/10/2027, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Cancer Institute, under the National Institutes of Health, is seeking meritorious proposals for the Carcinogen Hazard Assessment Monographs Program (CHAMP) Initiative. This solicitation, identified as RFA-CA-28-013, aims to fund projects that critically and systematically evaluate scientific evidence regarding carcinogenic hazards to humans to better inform cancer research, control, and prevention efforts. Interested applicants must submit their proposals by the response deadline of February 10, 2027. This opportunity is categorized as an R01 grant, and it is explicitly noted that clinical trials are not allowed under this specific funding program.

General Info

NCI seeks R01 proposals for carcinogenic hazard assessments by February 10, 2027.

Agency

National Institutes Of Health → National Cancer Institute

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseSolicitation

PostedOct 9

Solicitation

Response DeadlineFeb 10

Submission deadline

Response Deadline

02/10/2027, 12:00:00 AM UTCin 4 months

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyNational Institutes Of Health → National Cancer Institute

ContactsNo contacts available

OfficeUSA

Organization / AgencyNational Institutes Of Health → National Cancer Institute

Office AddressUSA

ContactsNo contact information available

Full Description

Show more

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute invites applications to the Carcinogen Hazard Assessment Monographs Program (CHAMP) Initiative . NCI seeks meritorious proposals to critically and systematically evaluate the scientific evidence on carcinogenic hazards to humans. Identifying potential carcinogens is essential for guiding and advancing cancer research, as well as informing cancer control and prevention efforts.

Similar Contracts

Same NAICS industry code

Geospatial Post-Processing SpecialistThe Geospatial Post-Processing Specialist subcontract involves providing technical processing of raw imagery for prime contractors working on Government of Yukon Geomatics projects. The scope of work includes executing orthorectification, image enhancement, atmospheric correction, and general post-processing. These tasks must be performed using high-performance computing and specialized orthorectification software to ensure all deliverables meet strict positional accuracy and projection format requirements. This opportunity is categorized under NAICS code 541715 and was posted on October 16, 2026, with a response deadline of November 10, 2026. The primary objective is the delivery of high-quality orthorectified and processed imagery products that adhere to the specific standards set by the Government of Yukon.

Government of Yukon

POSTED

DEADLINE

Digital Elevation Model (DEM) / Elevation Product SupplierThis subcontract opportunity is for a Digital Elevation Model and Elevation Product Supplier to support prime contractors on Government of Yukon Geomatics Yukon projects. The selected supplier will be responsible for generating Digital Elevation Models, Digital Terrain Models, and other elevation-based geospatial products. These deliverables must be created using photogrammetric workstations and stereo-processing software, derived from either aerial or satellite data. The supplier must ensure all products adhere to specific projection formats and vertical accuracy standards, with final data files delivered in ASCII or GeoTIFF formats. This procurement falls under NAICS code 541715, with a response deadline set for November 10, 2026.

Government of Yukon

POSTED

DEADLINE

Satellite Imagery ProviderThis subcontract opportunity is for a Satellite Imagery Provider to support prime contractors on Government of Yukon Geomatics Yukon projects. The selected provider will be responsible for capturing or granting access to mono and stereo satellite imagery using optical and radar constellations and archives. Deliverables include raw or processed imagery files and associated metadata, with specific requirements regarding resolution, image type, acquisition windows, and the management of cloud obscuration levels based on defined areas of interest. The solicitation was posted on October 16, 2026, with a response deadline of November 10, 2026. This procurement falls under NAICS code 541715 and is managed by the Government of Yukon. Interested parties can find further details through the official bids and tenders portal.

Government of Yukon

POSTED

DEADLINE

Tritium Testing Facility ServicesThe Tritium Testing Facility Services subcontract, issued by the UK Atomic Energy Authority, seeks a provider to supply a licensed facility capable of hosting, commissioning, and operating a tritium-compatible test rig. The selected provider will be responsible for managing tritium handling and operating the rig under representative VAC-ITS conditions to deliver critical operational data and test results for prime contractors. A fundamental requirement for this engagement is that the facility must possess the necessary nuclear and radiological regulatory approvals to ensure safe and compliant operations. Interested parties must submit their responses by November 16, 2026, in accordance with the solicitation posted on October 16, 2026.

UK Atomic Energy Authority

POSTED

DEADLINE

AI/ML Algorithm DevelopmentThis subcontract for AI/ML Algorithm Development supports the Department of Defense and NSWC Dahlgren in advancing autonomous kill chain projects. The scope of work involves the research, design, development, and training of machine learning models, specifically focusing on algorithms for perception, planning, decision-making, and action. A primary objective is the creation of persistent world models to enhance weapon and perception autonomy. The selected provider will be responsible for delivering fully trained machine learning models, algorithmic frameworks, and integrated perception systems. This effort falls under NAICS code 541715 and is scheduled for performance in the 22448 zip code area, with a response deadline set for March 11, 2027.

POSTED

DEADLINE

Research, Development, Test and Evaluation (RDT&E)This subcontract opportunity, titled Research, Development, Test and Evaluation (RDT&E), is issued by the Department of Defense through the W6QK Acc-Apg agency. The project focuses on conducting scientific research and experimental development to support prime contractors on Army and DoD initiatives. The scope of work encompasses basic, applied, and exploratory research, as well as modeling, simulation, and prototyping and fabrication support. To be successful, the contractor must possess advanced simulation software and dedicated prototyping and fabrication facilities to deliver research findings, simulation models, prototypes, and comprehensive test reports. The performance of this contract will take place at Aberdeen Proving Ground, zip code 21005. The opportunity was posted on October 16, 2026, with a response deadline set for November 12, 2026, at 4:59 PM. The work is categorized under NAICS code 541715, reflecting its focus on research and experimental development within the natural sciences and engineering.

POSTED

DEADLINE

Autonomous and Robotic Surgical Systems DevelopmentThis subcontract focuses on the development of autonomous and semi-autonomous medical systems and robotic surgical platforms to support prime contractors on projects for the DARPA Biological Technologies Office. The scope of work involves the research, design, and prototyping of robotic surgical tools and autonomous control systems specifically engineered for use in resource-limited settings. Successful execution requires specialized expertise in precision sensors and robotic actuators to ensure the delivery of functional system architectures and prototypes. Managed under the Department of Defense and the Defense Advanced Research Projects Agency, the opportunity is categorized under NAICS code 541715. The solicitation was posted on October 16, 2026, with a response deadline set for November 15, 2026.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Ionospheric Research Analysis and ReportingThe Ionospheric Research Analysis and Reporting subcontract involves providing specialized scientific analysis and technical documentation focused on solar, solar wind, and ionospheric effects for prime contractors supporting AFRL research projects. The scope of work includes analyzing transition laboratory results and creating presentation materials for technical reviews. Key deliverables for this effort are Final Scientific and Technical Reports and Quarterly Status Reports. This opportunity is managed by the Department of Defense under the AFRL Rvk agency and will be performed in Albuquerque. Due to the nature of the research, a valid U.S. Secret clearance is required for all personnel. Interested parties should note the response deadline of November 5, 2026, and the associated NAICS code 541715.

FA9453 Afrl Rvk

POSTED

DEADLINE

Ionospheric Model Integration ServicesThe Ionospheric Model Integration Services subcontract, issued by the Department of Defense under the AFRL Rvk agency, focuses on the integration and enhancement of scientific models for prime contractors supporting SSC enterprise solutions. The scope of work involves integrating the SEIM.STRES, OASIS, and RIPE model frameworks, as well as developing new models for enterprise deployment. Key deliverables include enhanced model code, integrated software modules, and comprehensive deployment documentation. Performance for this contract will take place in Albuquerque. Due to the nature of the work, personnel must possess a valid U.S. Secret clearance and maintain strict compliance with DD Form 254 requirements. The opportunity is categorized under NAICS code 541715, with a response deadline set for November 5, 2026.

FA9453 Afrl Rvk

POSTED

DEADLINE

Underwater and Air Explosion Computational AnalysisThis subcontract, titled Underwater and Air Explosion Computational Analysis, supports the Department of Defense through NSWC Carderock. The project involves performing high-fidelity computational analyses and simulations of Navy platforms and vehicles to evaluate their response to underwater and air explosions. Utilizing FEM, CFD, and structural analysis tools, the contractor will simulate shock environments resulting from contact weapon attacks, near-misses, and far-field explosions to provide critical technical reports and validation assessments for prime contractors on NSWCCD projects. The work is based in Bethesda, Maryland, and falls under NAICS code 541715. Due to the sensitive nature of the simulations and the agency involved, personnel are required to maintain a security clearance and hold Cyber Workforce certification. Interested parties must respond by November 24, 2026.

POSTED

DEADLINE

in about 1 month

Call 03 M-DASH - Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II)

Solicitation # FA238426SB007

The Joint All Domain Persistent Adaptive Collaborative Technologies II (JADPACT II) project, specifically the Multi-Decision Advantage Sprint for Human-Machine Teaming (M-DASH), is a research effort led by the Air Force Research Laboratory. The program aims to develop Human-Machine Teaming concepts and AI/automation capabilities to provide Battle Managers with decision advantage within the Combined Joint All-Domain Command and Control (CJADC2) framework. The effort focuses on the Transformational Model for Decision Advantage (TM-DA) to bridge the gap between operational concepts and software design, specifically requiring solutions that address three decision services: PAE, MEF, and GBC. The M-DASH event is a two-week simulation sprint scheduled for January 25 to February 5, 2027, in Las Vegas, Nevada. The government anticipates awarding Firm Fixed Price contracts or Other Transaction agreements with a maximum value of 100,000 dollars per selected offeror, out of a total estimated program cost of 600,000 dollars. Payment is issued as a single sum upon the conclusion of the event and the successful delivery of a Technical Review Presentation Package, which must include an end-of-event presentation, a technology survey, and simulated run digital audit logs. Eligibility for award requires offerors to have a CMMC Level 1 Self assessment and undergo a rigorous Science and Technology Protection risk review for all senior and key personnel. Proposals were due by October 21, 2026, and were subject to strict page limits for both the proposal and the Statement of Work. All deliverables must be submitted electronically to a government-controlled repository, and contractors must comply with AFRL supplemental requirements regarding patent rights, CUI marking, and security risk disclosures.

FA2384 USAF Afmc Afrl Pzl Afrl Rakh

POSTED

DEADLINE

R--AREMP AND WATER SAMPLE ANALYSIS

Solicitation # 140L4326Q0124

Solicitation 140L4326Q0124, issued by the Bureau of Land Management Oregon State Office, seeks a firm fixed-price commercial service contract for the analysis of 165 water samples for the AREMP Program. The scope of work requires the analysis of Total Nitrogen and Total Phosphorus using alkaline persulfate digestion methods, specifically adhering to Lachat QuikChem and EPA standards. The period of performance is scheduled from October 31, 2026, to March 31, 2027, with a required laboratory turnaround time of 60 days from the receipt of samples. This acquisition is set aside for Women-Owned Small Businesses, Economically Disadvantaged Women-Owned Small Businesses, and 8(a) participants under NAICS code 541715. The government will award the contract to the responsible offeror determined to be most advantageous based on price and past performance. Quotations must be submitted in two parts, consisting of a price section and a non-price section that includes details on three similar projects completed as a prime contractor within the last three years. Technical requirements are stringent, necessitating a QAPP-style validation plan, specific Method Detection Limit studies per 40 CFR 136.6, and an ongoing quality control plan. Payment will be processed electronically through the Invoice Processing Platform System. Multiple amendments have been issued to clarify analytical methods, update the NAICS code, and extend the quotation deadline to October 21, 2026.

Oregon State Office

POSTED

DEADLINE

More opportunities from National Institutes Of Health → National Cancer Institute

Same awarding agency

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Solicitation # RFA-CA-28-004

The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.

Blood and Organ Banks

POSTED

DEADLINE

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Solicitation # PAR-28-014

The National Cancer Institute, under the National Institutes of Health, is soliciting applications for solicitation PAR-28-014 to investigate the causes and biological mechanisms of sporadic non-hereditary early-onset cancers in adults aged 18 to 49. The primary goal of this initiative is to understand the rising incidence of these cancers to improve prevention and control strategies. Research should specifically target environmental or lifestyle drivers across various demographics, the biological host responses involved, or the development of more effective methods for identifying high-risk individuals. This funding opportunity supports both standard research projects and exploratory or developmental studies through a grant award instrument, with clinical trials being optional. Interested parties must submit their applications by the deadline of October 12, 2029.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in almost 3 years

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Solicitation # PAR-28-022

The National Cancer Institute, potentially in collaboration with the National Institute of Dental and Craniofacial Research, is soliciting applications for P50 Research Center Grants for Specialized Programs of Research Excellence. This program supports investigator-initiated translational research focused on the prevention, early detection, diagnosis, and treatment of organ-specific cancers or closely related cancer groups. Eligible research must be grounded in human biology using genetic, molecular, biochemical, structural, or cellular experimental approaches and must achieve a translational human endpoint within the grant period. Under solicitation number PAR-28-022, this opportunity covers the years 2027, 2028, and 2029 and requires the inclusion of clinical trials. The notice was posted on October 14, 2026, with a final response deadline of September 26, 2029. This initiative serves as a re-issuance of PAR-23-284 to continue funding state-of-the-art research aimed at improving clinical outcomes for cancer patients.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in almost 3 years

Notice of Change in Application Due Date for RFA-CA-27-005 "Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)"

Solicitation # NOT-CA-26-020

This notice issued by the National Cancer Institute of the National Institutes of Health serves to amend the application timeline for the Glioblastoma Therapeutics Network clinical trial solicitation, RFA-CA-27-005. The primary modification is the addition of a second application due date on January 11, 2027, for new, renewal, resubmission, and revision applications. Under this new cycle, the scientific merit review is scheduled for June 2027, followed by an advisory council review in August 2027, with an earliest start date of December 2027. The expiration date for this specific window is January 12, 2027. All other terms and conditions of the original notice of funding opportunity remain unchanged.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Solicitation # PAR-28-057

The National Cancer Institute is soliciting applications under solicitation PAR-28-057 to establish the Management and Data Coordination Unit as a key scientific component of the Pancreatic Cancer Detection Consortium. This initiative focuses on the early detection of pancreatic ductal adenocarcinoma and the characterization of precursor lesions to identify high-risk patients, aligning with the NCI's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma. The selected unit will be responsible for providing critical infrastructure and collaborative support, including study design, protocol development, statistical analysis, and comprehensive data management. Additionally, the unit will oversee the coordination of biorepository building and provide the necessary organizational and logistics support to ensure the successful operation of the consortium. Applications must be submitted by the deadline of May 26, 2027.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Solicitation # PAR-28-056

The National Cancer Institute is soliciting applications for Research Units as part of the Pancreatic Cancer Detection Consortium to advance the early detection of pancreatic ductal adenocarcinoma and the characterization of precursor lesions. These multi-disciplinary teams will focus on developing and testing molecular and imaging biomarkers to identify high-risk patients and those with lesions likely to progress to cancer. Key research activities include the use of machine learning for biomarker discovery, conducting validation studies, and collecting longitudinal biospecimens for a centralized biorepository. Under solicitation PAR-28-056, the selected Research Units are required to engage in collaborative efforts, sharing data and biospecimens across the consortium. The initiative aligns with the NCI's scientific framework for pancreatic cancer by prioritizing the identification of patients who could benefit from early intervention based on genetic factors, family history, or existing precursor lesions. Applications for this federal opportunity are due by November 6, 2029.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in about 3 years

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS